Strong financial performance underpinned by branded product progressChippenham, UK – 21 May 2013: Vectura Group plc (LSE: VEC) (“Vectura”), which specialises in developing inhaled therapies, principally for the treatment of airway diseases, announces ...
[Published Vectura Group - May 21 2013]